The climate emergency for rheumatologists: where do we stand?

被引:0
|
作者
Mruthyunjaya, Prakashini [1 ]
Sondur, Suhas [2 ]
Ahmed, Sakir [1 ]
Grainger, Rebecca [3 ]
机构
[1] KIIT Univ, Kalinga Inst Med Sci, Dept Clin Immunol & Rheumatol, Bhubaneswar, India
[2] KIIT Univ, Kalinga Inst Med Sci, Dept Orthopaed, Bhubaneswar, India
[3] Univ Otago, Dept Med, Wellington, New Zealand
关键词
Autoimmunity; Climate change; Epigenetics; Emerging infections; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AIR-POLLUTION EXPOSURES; RHEUMATOID-ARTHRITIS; WEATHER CONDITIONS; ZIKA VIRUS; OXIDATIVE STRESS; CARBON FOOTPRINT; T-CELLS; OSTEOARTHRITIS; CHIKUNGUNYA;
D O I
10.1007/s10067-024-07284-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Climate change and pollution are a major existential threat. Healthcare contributes a noteworthy 4-6% to the total carbon footprint and 5-7% of the total greenhouse gas (GHG) emissions. Environmental pollution and modern lifestyles are also contributing to the increased prevalence of autoimmune and lifestyle-related rheumatic disease. In this review, we assess both the effects of rheumatological practice on climate change and the potential impact of climate change on rheumatological diseases. Preliminary evidence suggests that climate change is linked with the inception or exacerbation of some of the autoimmune and inflammatory rheumatic diseases (AIRDs) like rheumatoid arthritis, lupus, systemic sclerosis, and reactive arthritis. Furthermore, with rampant industrialization and pollution, emerging infections such as Dengue, Zika virus, and chikungunya have emerged as triggers of inflammatory arthritis. Strategies at different levels are proposed to mitigate the effect of the healthcare industry and the community on the environment. The rheumatology community can acknowledge and begin to address the challenges of climate change and health.
引用
收藏
页码:573 / 582
页数:10
相关论文
共 50 条
  • [21] Where do we stand in the OECD?
    Buske, L
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1997, 156 (03) : 464 - 464
  • [22] Where do we stand with hepatoblastoma?
    Schnater, JM
    Köhler, SE
    Lamers, WH
    von Schweinitz, D
    Aronson, DC
    CANCER, 2003, 98 (04) : 668 - 678
  • [23] Inflation: Where do we stand?
    Martin, J
    INTERNATIONAL JOURNAL OF MODERN PHYSICS A, 2005, 20 (19): : 4676 - 4682
  • [24] GFIS - Where do we stand?
    Anon
    IUFRO News, 2002, 31 (02):
  • [25] The GSEs: Where do we stand?
    Poole, William
    FEDERAL RESERVE BANK OF ST LOUIS REVIEW, 2007, 89 (03): : 143 - 151
  • [26] VITILIGO - WHERE DO WE STAND
    ORTONNE, JP
    BOSE, SK
    PIGMENT CELL RESEARCH, 1993, 6 (02): : 61 - 72
  • [27] Where do we stand on econophysics?
    Carbone, A.
    Kaniadakis, G.
    Scarfone, A. M.
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2007, 382 (01) : XI - XIV
  • [28] WHERE DO WE STAND WITH PPIS
    WELSH, JS
    AMERICAN PHARMACY, 1979, 19 (12): : 12 - 14
  • [29] Delirium: Where do we stand?
    Pae C.-U.
    Marks D.M.
    Han C.
    Patkar A.A.
    Masand P.
    Current Psychiatry Reports, 2008, 10 (3) : 240 - 248
  • [30] Hyperfractionation: Where do we stand?
    BeckBornholdt, HP
    Dubben, HH
    LiertzPetersen, C
    Willers, H
    RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) : 1 - 21